MedStar Health News

The first clinical trial to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer is now enrolling patients at Georgetown Lombardi Comprehensive Cancer Center.

Barbara S. Bregman, PhD, senior research scientist and director of education and training with MedStar NRH Research Division, and a professor in the Departments of Neuroscience and Rehabilitation Medicine at Georgetown University Medical Center and the Center for Brain Plasticity at Georgetown University, is the recipient of the 28th Annual John W. Goldschmidt Award.

In 2013 at the age of 53, Semple, a healthy trialthlete, was diagnosed with advanced cancer of the thymus, a small gland in the neck that produces T cells for the immune system.

The Memory Disorders Program at Georgetown University is seeking volunteers to participate in an international clinical trial of a drug that, in an early phase study, has demonstrated promise in slowing mental decline in Alzheimer’s disease.

Georgetown University Medical Center will host the first summit to explore gender differences of female brain injuries

New research at MedStar Rehabilitation Network aims to spot and treat Urinary Tract Infections (UTIs) for spinal cord injury patients, who are being treated for bladder dysfunction. Through a grant pr...